N = 1326; age ≥ 65 y
Invasive BC; < 30 mm; N0; ER+; low risk
All had adjuvant endocrine therapy
Kunkler IH, et al. Lancet Oncol 2015;16:266-73.
Less local treatment: The role of RT in BCT